These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 29141072)

  • 1. Association of CETP Gene Variants With Risk for Vascular and Nonvascular Diseases Among Chinese Adults.
    Millwood IY; Bennett DA; Holmes MV; Boxall R; Guo Y; Bian Z; Yang L; Sansome S; Chen Y; Du H; Yu C; Hacker A; Reilly DF; Tan Y; Hill MR; Chen J; Peto R; Shen H; Collins R; Clarke R; Li L; Walters RG; Chen Z;
    JAMA Cardiol; 2018 Jan; 3(1):34-43. PubMed ID: 29141072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Benefits and Harms Associated With Genetic Cholesteryl Ester Transfer Protein Deficiency in the General Population.
    Nordestgaard LT; Christoffersen M; Lauridsen BK; Afzal S; Nordestgaard BG; Frikke-Schmidt R; Tybjærg-Hansen A
    JAMA Cardiol; 2022 Jan; 7(1):55-64. PubMed ID: 34613338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk.
    Ference BA; Kastelein JJP; Ginsberg HN; Chapman MJ; Nicholls SJ; Ray KK; Packard CJ; Laufs U; Brook RD; Oliver-Williams C; Butterworth AS; Danesh J; Smith GD; Catapano AL; Sabatine MS
    JAMA; 2017 Sep; 318(10):947-956. PubMed ID: 28846118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint Genetic Inhibition of PCSK9 and CETP and the Association With Coronary Artery Disease: A Factorial Mendelian Randomization Study.
    Cupido AJ; Reeskamp LF; Hingorani AD; Finan C; Asselbergs FW; Hovingh GK; Schmidt AF
    JAMA Cardiol; 2022 Sep; 7(9):955-964. PubMed ID: 35921096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition.
    Kettunen J; Holmes MV; Allara E; Anufrieva O; Ohukainen P; Oliver-Williams C; Wang Q; Tillin T; Hughes AD; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT; Salomaa V; Järvelin MR; Perola M; Davey Smith G; Chaturvedi N; Danesh J; Di Angelantonio E; Butterworth AS; Ala-Korpela M
    PLoS Biol; 2019 Dec; 17(12):e3000572. PubMed ID: 31860674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The loss-of-function mutation of CETP affects HDLc levels but not ApoA1 in patients with acute myocardial infarction.
    Li W; Liu X; Huang C; Liu L; Tan X; Wang X
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):602-607. PubMed ID: 33358712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of peripheral lipoproteins and cholesteryl ester transfer protein in the vascular contributions to cognitive impairment and dementia.
    Poliakova T; Wellington CL
    Mol Neurodegener; 2023 Nov; 18(1):86. PubMed ID: 37974180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?
    Nurmohamed NS; Ditmarsch M; Kastelein JJP
    Cardiovasc Res; 2022 Nov; 118(14):2919-2931. PubMed ID: 34849601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Cholesteryl Ester Transfer Protein TaqIB Polymorphism with the Composite Ischemic Cardiovascular Disease Risk and HDL-C Concentrations: A Meta-Analysis.
    Guo SX; Yao MH; Ding YS; Zhang JY; Yan YZ; Liu JM; Zhang M; Rui DS; Niu Q; He J; Guo H; Ma RL
    Int J Environ Res Public Health; 2016 Sep; 13(9):. PubMed ID: 27608031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between a common variant of the cholesteryl ester transfer protein gene and the apolipoprotein E polymorphism: effects on plasma lipids and lipoproteins in a cohort of 7-year-old children.
    Rump P; Mensink RP; Hornstra G
    Nutr Metab Cardiovasc Dis; 2002 Dec; 12(6):317-24. PubMed ID: 12669678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-Wide Association Study of Cardiovascular Resilience Identifies Protective Variation in the
    Yu C; Bakshi A; Watts GF; Renton AE; Fulton-Howard B; Goate AM; Natarajan P; Chasman DI; Robman L; Woods RL; Guymer R; Wolfe R; Thao LTP; McNeil JJ; Tonkin AM; Nicholls SJ; Lacaze P
    J Am Heart Assoc; 2023 Nov; 12(21):e031459. PubMed ID: 37929782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel cholesteryl ester transfer protein promoter polymorphism (-971G/A) associated with plasma high-density lipoprotein cholesterol levels. Interaction with the TaqIB and -629C/A polymorphisms.
    Le Goff W; Guerin M; Nicaud V; Dachet C; Luc G; Arveiler D; Ruidavets JB; Evans A; Kee F; Morrison C; Chapman MJ; Thillet J
    Atherosclerosis; 2002 Apr; 161(2):269-79. PubMed ID: 11888509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesteryl ester transfer protein genetic polymorphisms, HDL cholesterol, and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis.
    Tsai MY; Johnson C; Kao WH; Sharrett AR; Arends VL; Kronmal R; Jenny NS; Jacobs DR; Arnett D; O'Leary D; Post W
    Atherosclerosis; 2008 Oct; 200(2):359-67. PubMed ID: 18243217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common lipid-altering gene variants are associated with therapeutic intervention thresholds of lipid levels in older people.
    Murray A; Cluett C; Bandinelli S; Corsi AM; Ferrucci L; Guralnik J; Singleton A; Frayling T; Melzer D
    Eur Heart J; 2009 Jul; 30(14):1711-9. PubMed ID: 19435741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.
    Brousseau ME; O'Connor JJ; Ordovas JM; Collins D; Otvos JD; Massov T; McNamara JR; Rubins HB; Robins SJ; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1148-54. PubMed ID: 12117730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism in the CETP gene region, HDL cholesterol, and risk of future myocardial infarction: Genomewide analysis among 18 245 initially healthy women from the Women's Genome Health Study.
    Ridker PM; Paré G; Parker AN; Zee RY; Miletich JP; Chasman DI
    Circ Cardiovasc Genet; 2009 Feb; 2(1):26-33. PubMed ID: 20031564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk.
    Thompson A; Di Angelantonio E; Sarwar N; Erqou S; Saleheen D; Dullaart RP; Keavney B; Ye Z; Danesh J
    JAMA; 2008 Jun; 299(23):2777-88. PubMed ID: 18560005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesteryl Ester Transfer Protein Genetic Variants Associated with Risk for Type 2 Diabetes and Diabetic Kidney Disease in Taiwanese Population.
    Huang YC; Chen SY; Liu SP; Lin JM; Lin HJ; Lei YJ; Chung YC; Chen YC; Wang YH; Liao WL; Tsai FJ
    Genes (Basel); 2019 Oct; 10(10):. PubMed ID: 31597401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of CETP gene -629C/A polymorphism on the efficacy of atorvastatin treatment and clinical outcome].
    Gao J; Cong HL; Mao YM; Liu Y; Zhang N; Chen Q; Liu T; Cui R
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Oct; 30(5):553-8. PubMed ID: 24078569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mendelian Randomization Implicates High-Density Lipoprotein Cholesterol-Associated Mechanisms in Etiology of Age-Related Macular Degeneration.
    Burgess S; Davey Smith G
    Ophthalmology; 2017 Aug; 124(8):1165-1174. PubMed ID: 28456421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.